Ingredient or product comparison
GHK-Cu Timing: Morning vs Evening vs Split-Dose
Once daily (evening) Sharp peak at 30–60 min, below threshold by morning 6–8 hours active, 16–18 hours subtherapeutic Convenience for non-critical applications Long trough period limits tissue repair continuity Logistically simple but pharmacologically subopti
This source-based comparison does not add ratings or recommend a winner.
- Once daily (evening)
- Sharp peak at 30–60 min, below threshold by morning
- 6–8 hours active, 16–18 hours subtherapeutic
- Convenience for non-critical applications
- Long trough period limits tissue repair continuity
- Logistically simple but pharmacologically suboptimal for recovery applications
- Twice daily (12-hour intervals)
- Sustained levels above threshold for 18–20 hours
- Near-continuous receptor occupancy with brief overlap
- Most recovery and anti-aging protocols
- Requires morning and evening administration
- Ideal balance of efficacy and practicality for most users
- Three times daily (8-hour intervals)
- Consistent therapeutic plasma concentration 24 hours
- Maximum receptor saturation and signaling duration
- Acute injury, post-surgical healing, intensive protocols
- Midday dose may be inconvenient; not necessary for maintenance
- Best option for time-sensitive recovery but logistically demanding
- Single megadose (3mg+)
- Supraphysiologic peak followed by rapid clearance
- Receptor saturation within 1 hour, then prolonged subtherapeutic period
- None. Excess peptide is wasted
- High cost per dose, increased injection site reaction risk
- Avoid. Does not improve outcomes vs split dosing and increases adverse event likelihood